Scalp high‐frequency oscillations differentiate neonates with hypoxic–ischemic encephalopathy with and without electroencephalographically confirmed seizures
Authors:
- Panagiota KaratzaPKPanagiota Karatza
- Dorottya CserpanDCDorottya Cserpan
- Antonio Giulio GennariAGAntonio Giulio Gennari
- Anina GrubenmannAGAnina Grubenmann
- Santo Pietro Lo BiundoSBSanto Pietro Lo Biundo
- Francesco PisaniFPFrancesco Pisani
- Johannes SarntheinJSJohannes Sarnthein
- Georgia RamantaniGRGeorgia Ramantani
Open Access
Abstract
Objective: Hypoxic–ischemic encephalopathy (HIE) is a leading cause of neonatal seizures, but seizure detection is challenging when continuous electroencephalography (EEG) is unavailable and neonates undergo only a single routine EEG. Biomarkers derived from routine EEG may aid identification of neonates with seizures. We investigated whether scalp high‐frequency oscillation (HFO) rates derived from the first eligible routine EEG (1) differentiate neonates with HIE with and without seizures; and (2) contribute to seizure classification alongside established clinical, neurophysiological, and imaging biomarkers. Methods: We retrospectively analyzed routine scalp EEG recordings from 33 term neonates with HIE (17 with seizures, 16 without), obtained at a mean postnatal age of 4 ± 3 days. The mean analyzed EEG duration was 38 ± 14 min in neonates with seizures and 36 ± 20 min in those without. HFO rates in sleep segments were quantified using a validated automated detector. Results: Scalp HFO rates were significantly higher in neonates with seizures than in those without (.12 ± .11 vs. .03 ± .02 HFOs/min/channel, adjusted p = .02). An HFO rate threshold of .07 HFOs/min/channel optimally discriminated neonates who had seizures from those who did not (area under the curve [AUC] = .81). HFO rates did not differ significantly according to HIE severity, therapeutic hypothermia, antiseizure medication response, EEG background activity, or magnetic resonance imaging (MRI) abnormalities. Multivariable models incorporating HFO rate, EEG background activity, and MRI findings showed discrimination (AUC = .92, 95% confidence interval [CI] = .69–1.00 for logistic regression; AUC = 1.00, 95% CI = .75–1.00 for random forest), with HFO rate as the strongest contributor to seizure classification. Significance: These findings support scalp HFO rate as a potential electrophysiological biomarker of seizure occurrence in neonatal HIE , complementary to EEG background assessment and MRI findings. Prospective studies are needed to determine whether HFOs can predict subsequent seizures.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (10008856)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (204651)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (208184)
This publication has 41 references indexed in Scilit:
- Rethinking the definition of neonatal status epilepticusEuropean Journal of Pediatrics, 2025
- Scalp high‐frequency oscillations differentiate neonates with seizures from healthy neonatesEpilepsia Open, 2023
- Scalp HFO rates are higher for larger lesionsEpilepsia Open, 2022
- High-frequency oscillations in scalp EEG: A systematic review of methodological choices and clinical findingsClinical Neurophysiology, 2022
- Variation of scalp EEG high frequency oscillation rate with sleep stage and time spent in sleep in patients with pediatric epilepsyClinical Neurophysiology, 2022
- High-frequency oscillations recorded with surface EEG in neonates with seizuresClinical Neurophysiology, 2021
- Consensus protocol for EEG and amplitude-integrated EEG assessment and monitoring in neonatesClinical Neurophysiology, 2021
- Scalp EEG interictal high frequency oscillations as an objective biomarker of infantile spasmsClinical Neurophysiology, 2020
- Effects of intravenous diazepam on high-frequency oscillations in EEGs with CSWSBrain and Development, 2013
- Development of epilepsy in newborns with moderate hypoxic-ischemic encephalopathy and neonatal seizuresBrain and Development, 2009